NuCana (NCNA) News Today $3.69 -0.30 (-7.52%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$3.78 +0.09 (+2.30%) As of 09/19/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NCNA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period NuCana plc: NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025September 5, 2025 | finanznachrichten.deNuCana Compliant with All Nasdaq Continued Listing CriteriaSeptember 5, 2025 | globenewswire.comNuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025September 3, 2025 | globenewswire.comNuCana Reports Q2 2025 Financial Results Highlighting Operating LossAugust 20, 2025 | msn.comNuCana Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 20, 2025 | globenewswire.comNuCana PLC (ADR) trading halted, news pendingAugust 9, 2025 | msn.comNuCana Announces ADS Ratio ChangeAugust 1, 2025 | globenewswire.comNuCana plc: NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM ExecutionJuly 21, 2025 | finanznachrichten.deNuCana Cancels All Outstanding Series A Warrants Following Strategic ATM ExecutionJuly 21, 2025 | globenewswire.comNuCana plc (NCNA) Latest Stock News & Headlines - Yahoo FinanceJuly 13, 2025 | finance.yahoo.comNCNA - NuCana PLC ADR Price vs Fair Value | MorningstarJuly 11, 2025 | morningstar.comMNuCana Announces Plan to Implement ADS Ratio ChangeJuly 11, 2025 | globenewswire.comNuCana PLC ADR Stock Grades | NCNA - Barron'sJune 29, 2025 | barrons.comnucana plc announces annual report release and upcoming agmJune 7, 2025 | uk.investing.comNuCana Reports Reduced Q1 2025 Losses Amid Financial ChallengesJune 2, 2025 | tipranks.comNuCana Reports First Quarter 2025 Financial Results and Provides Business UpdateJune 2, 2025 | globenewswire.comNuCana plc: NuCana Prices $7 Million Registered Direct OfferingMay 6, 2025 | finanznachrichten.deEuropean Equities Traded in the US as American Depositary Receipts Drop Sharply in Wednesday TradingApril 30, 2025 | msn.comNuCana plc: NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business UpdateMarch 22, 2025 | finanznachrichten.deNuCana Reports Q4 EPS GBP (1) vs. GBP (14)March 21, 2025 | markets.businessinsider.comNuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business UpdateMarch 20, 2025 | globenewswire.comNuCana Calls for Shareholder Vote on Key ResolutionsMarch 18, 2025 | tipranks.comBank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Tuesday TradingFebruary 25, 2025 | msn.comAurion Biotech Appoints Donald Munoz as Chief Financial OfficerFebruary 10, 2025 | businesswire.comEuropean Equities Traded in the US as American Depositary Receipts Fall in Monday TradingFebruary 3, 2025 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday TradingJanuary 22, 2025 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for WeekDecember 13, 2024 | msn.comNuCana Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 25, 2024 | globenewswire.comNuCana’s NUC-3373 Shows Promise in Cancer TreatmentNovember 13, 2024 | markets.businessinsider.comEuropean Equities Traded in the US as American Depositary Move Higher in Monday TradingNovember 12, 2024 | msn.comNuCana announces initial data from Phase 1b/2 modular study of NUC-3373November 12, 2024 | markets.businessinsider.comNuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or DocetaxelNovember 11, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Rise FridayOctober 18, 2024 | msn.comTruist Financial Sticks to Their Buy Rating for Nucana (NCNA)October 16, 2024 | markets.businessinsider.comBaillie Gifford's Strategic Acquisition of NuCana PLC SharesOctober 4, 2024 | gurufocus.comEuropean Equities Traded in the US as American Depositary Receipts Flat in Friday TradingSeptember 27, 2024 | msn.comNuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United StatesSeptember 25, 2024 | markets.businessinsider.comNuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United StatesSeptember 25, 2024 | globenewswire.comNUCANA SP.ADR 25/ LS-,04 (N04.MU)September 17, 2024 | uk.finance.yahoo.comNuCana plc (N04.F)September 17, 2024 | uk.finance.yahoo.comNuCana PLC ADRSeptember 17, 2024 | wsj.comNuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock SurgesSeptember 16, 2024 | finance.yahoo.comOppenheimer Sticks to Their Buy Rating for Nucana (NCNA)September 16, 2024 | markets.businessinsider.comNuCana ADRs Nearly Double on Positive Data From Metastatic Melanoma TreatmentSeptember 16, 2024 | marketwatch.comNuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024September 14, 2024 | globenewswire.comWilliam Blair Downgrades NuCana plc - Depositary Receipt () (NCNA)August 31, 2024 | msn.comNuCana plc: NuCana Announces Update for Phase 2 Randomized Colorectal Cancer StudyAugust 30, 2024 | finanznachrichten.deNuCana plunges despite trial setback for cancer drugAugust 30, 2024 | msn.comNuCana Shares Plunge 60% After Colorectal-Cancer Study DiscontinuedAugust 30, 2024 | marketwatch.comNuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing DataAugust 30, 2024 | msn.com Get NuCana News Delivered to You Automatically Sign up to receive the latest news and ratings for NCNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NCNA Media Mentions By Week NCNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NCNA News Sentiment▼0.000.78▲Average Medical News Sentiment NCNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NCNA Articles This Week▼00▲NCNA Articles Average Week Get the Latest News and Ratings for NCNA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for NuCana and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Bio-Path News Today Vincerx Pharma News Today Orgenesis News Today Syros Pharmaceuticals News Today Virpax Pharmaceuticals News Today Trevena News Today Ainos News Today BriaCell Therapeutics News Today Novartis News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NCNA) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share NuCana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NCNA Stock Alerts